Drägerwerk Reports Strong Performance in First Nine Months of 2024

Drägerwerk AG & Co. KGaA has reported a robust performance for the first nine months of 2024. The company's order intake surpassed last year's figures, reaching approximately EUR 2,421 million, an increase of EUR 17 million. Despite a slight 0.4% decrease in net sales to EUR 2,295.1 million compared to the previous year, Dräger's Earnings Before Interest and Taxes (EBIT) rose by 4.2% to EUR 80.1 million, enhancing the EBIT margin to 3.5%.

The safety division saw a 6.5% increase in order intake, leading to a 5.5% rise in net sales. Conversely, the medical division experienced a 2.1% decline in order intake due to reduced demand for ventilators from China. However, the sale of non-core assets and improved delivery capacities bolstered overall earnings.

Dräger confirmed its annual forecast, anticipating net sales growth between 1.0% and 5.0% and maintaining confidence in achieving the upper end of its EBIT margin target of 2.5% to 5.5%.